Invitae up on Citron support

Genetic testing outfit Invitae (NVTA +6.7%) is up on average volume in apparent response to a social media post that Citron Research has a long position with a $100 (321% upside) fair value target.

In Q1, revenue was up 47% to $40.6M, but shy of consensus. Sample volume was also up 47% to 94,000.

SA Authors rating is Bullish while Quant rating is Neutral.

https://seekingalpha.com/news/3478546-invitae-7-percent-citron-support